CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of early drug development software solutions, announced today that Mitsubishi Chemical Medience Corporation (MCM) has purchased the Provantis preclinical software solution.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of early drug development software solutions, announced today that Mitsubishi Chemical Medience Corporation (MCM) has purchased the Provantis preclinical software solution.